[Lecture Report] The 7th NIKKEI FT Communicable Diseases Conference – Strategies for Coexisting with Communicable Diseases: Japanese PPP Initiative through Technological Innovation- (The NIKKEI, November 6-7, 2020, Yokohama City, Kanagawa Prefecture)
date : 11/27/2020
On November 6 and 7, 2020, HGPI Chairman Dr. Kiyoshi Kurokawa and HGPI CEO and Board Member Mr. Ryoji Noritake spoke at various programs throughout both days of the 7th NIKKEI FT Communicable Diseases Conference, which was entitled “Strategies for Coexisting with Communicable Diseases: Japanese PPP Initiative through Technological Innovation.” The event was co-hosted by the NIKKEI and the Financial Times.
For details, please visit the event website, which can be found here.
Below is an excerpt from the program that included Dr. Kurokawa and Mr. Noritake. The full speaker list can be viewed here.
Friday, November 6, 2020
Lunch Session- BD Japan: The role of testing in communicable diseases~Learning from COVID-19
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Breakout Session A-1: Challenges and Efforts to Address the Threat of Infectious Diseases – Learning from the Cases of AMR and COVID-19
Discusser: Ryoji Noritake (HGPI Board Member and CEO)
Breakout Session A-2: Challenges and Efforts to Address the Threat of Infectious Diseases – Learning from the Cases of AMR and COVID-19
Discusser: Ryoji Noritake (HGPI Board Member and CEO)
Saturday, November 7, 2020
Keynote Session- Dr. Yasuhiro Suzuki, Former Vice-Minister for Health/Chief Medical & Global Health Officer, MHLW, Japan
Discusser: Kiyoshi Kurokawa (HGPI Chairman)
Special Session III: Speeches from Governors
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Special Session III: Speeches from Governors
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Agenda6- Coexisting with COVID-19 ~The Role of Japanese Initiatives
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Discusser: Kiyoshi Kurokawa (HGPI Chairman)
Summary Session
Discusser: Ryoji Noritake (HGPI Board Member and CEO)
Conclusion/Statement
Discusser: Ryoji Noritake (HGPI Board Member and CEO)
日本語
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Public Comment Submission] “Strategic Research and Innovation Action Plan by the European partnership on One Health AMR (Draft)” (May 30, 2024)
- [Policy Recommendations] Suggestions for Building a Resilient and Greener Health Care System Considering Sustainability and Environmental Concerns in the Revision of Medical, Nursing Care, and Disability Welfare Service Fees (December 6, 2023)
Featured Posts
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)
-
2024-07-31
[Policy Recommendations] Establishing a System That Makes Full Use of Primary Care Physicians and Can Respond to Complex Chronic Pain (July 31, 2024)